Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-06 Purchase |
2023-06-08 4:44 pm |
Satsuma Pharmaceuticals Inc. | STSA | TAKANASHI KEN Director 10% Owner |
22,053,581 | $0.91 | $20,068,759 | 24,847,694 (Indirect Direct) |
View |
| 2023-06-06 Purchase |
2023-06-08 4:24 pm |
Satsuma Pharmaceuticals Inc. | STSA | Shin Nippon Biomedical Laboratories Ltd. 10% Owner |
30,477,313 | $0.91 | $27,734,355 | 11,217,845 (Indirect Direct) |
View |
| 2022-11-21 Purchase |
2022-11-23 09:38 am |
Satsuma Pharmaceuticals Inc. | STSA | Leonard Braden Michael 10% Owner |
150,000 | $0.7116 | $106,740 | 6,590,000 (Indirect Direct) |
View |
| 2022-11-14 Purchase |
2022-11-16 4:32 pm |
Satsuma Pharmaceuticals Inc. | STSA | Leonard Braden Michael 10% Owner |
6,440,000 | $0.68234 | $4,394,273 | 6,440,000 (Indirect) |
View |
| 2022-11-14 Sale |
2022-11-16 4:05 pm |
Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner |
3,250,000 | $0.706 | $2,294,500 | 461,286 (Indirect) |
View |
| 2021-11-24 Purchase |
2021-11-29 4:30 pm |
Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner |
2,922 | $5.42 | $15,837 | 3,711,286 (Indirect) |
View |
| 2021-11-19 Purchase |
2021-11-23 4:30 pm |
Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner |
13,204 | $5.4778 | $72,329 | 3,708,364 (Indirect) |
View |
| 2021-11-10 Purchase |
2021-11-12 4:31 pm |
Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner |
17,563 | $5.9404 | $104,332 | 3,695,160 (Indirect) |
View |
| 2021-11-08 Purchase |
2021-11-10 4:30 pm |
Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner |
560 | $5.99 | $3,354 | 3,677,597 (Indirect) |
View |
| 2021-11-04 Purchase |
2021-11-08 4:33 pm |
Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner |
9,200 | $5.9393 | $54,642 | 3,677,037 (Indirect) |
View |
| 2021-11-02 Purchase |
2021-11-04 4:31 pm |
Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner |
8,880 | $5.64 | $50,083 | 3,667,837 (Indirect) |
View |
| 2021-10-29 Purchase |
2021-11-02 4:30 pm |
Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner |
44,651 | $5.71 | $254,957 | 3,658,957 (Indirect) |
View |
| 2021-10-27 Purchase |
2021-10-29 4:30 pm |
Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner |
54,663 | $5.4776 | $299,422 | 3,614,306 (Indirect) |
View |
| 2021-10-21 Purchase |
2021-10-25 4:31 pm |
Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner |
60,445 | $5.4503 | $329,442 | 3,559,643 (Indirect) |
View |
| 2021-10-19 Purchase |
2021-10-21 4:30 pm |
Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner |
128,243 | $5.1873 | $665,237 | 3,499,198 (Indirect) |
View |
| 2021-10-15 Purchase |
2021-10-19 5:13 pm |
Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner |
162,194 | $4.8389 | $784,845 | 3,370,955 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-08 Equity Swap |
2023-06-12 8:23 pm |
N/A N/A |
Satsuma Pharmaceuticals Inc. | STSA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Former 10% Owner |
5,914,252 | $0 | 0 (Indirect) |
View |
| 2023-06-06 Equity Swap |
2023-06-08 4:48 pm |
N/A N/A |
Satsuma Pharmaceuticals Inc. | STSA | O'Neil Thomas P. Chief Financial Officer |
13,877 | $0.91 | 0 (Direct) |
View |
| 2023-06-06 Equity Swap |
2023-06-08 4:45 pm |
N/A N/A |
Satsuma Pharmaceuticals Inc. | STSA | Shah Rajeev M. Director 10% Owner |
5,914,252 | $0.91 | 0 (Indirect) |
View |
| 2023-06-06 Equity Swap |
2023-06-08 4:31 pm |
N/A N/A |
Satsuma Pharmaceuticals Inc. | STSA | Kollins John A President and CEO |
305,911 | $0.91 | 0 (Direct) |
View |
| 2022-06-03 Option Award(A) |
2022-12-09 4:11 pm |
N/A 2032-06-02 |
Satsuma Pharmaceuticals Inc. | STSA | TAKANASHI KEN Director |
30,000 | $0 | 2,824,113 (Direct) |
View |
Ownership |
2022-11-16 3:48 pm |
N/A N/A |
Satsuma Pharmaceuticals Inc. | STSA | Leonard Braden Michael 10% Owner |
0 | $0 | 5,608,306 (Indirect) |
View |
| 2022-06-03 Option Award |
2022-06-07 5:40 pm |
N/A 2032-06-02 |
Satsuma Pharmaceuticals Inc. | STSA | O'Neil Thomas P. Chief Financial Officer |
190,000 | $0 | 190,000 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 5:39 pm |
N/A 2032-06-02 |
Satsuma Pharmaceuticals Inc. | STSA | ALBRECHT DETLEF Chief Medical Officer |
190,000 | $0 | 190,000 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 5:38 pm |
N/A 2032-06-02 |
Satsuma Pharmaceuticals Inc. | STSA | Kollins John A President and CEO |
505,000 | $0 | 505,000 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 5:38 pm |
N/A 2032-06-02 |
Satsuma Pharmaceuticals Inc. | STSA | Lukatch Heath Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 5:37 pm |
N/A 2032-06-02 |
Satsuma Pharmaceuticals Inc. | STSA | Sandoval Elisabeth Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 5:36 pm |
N/A 2032-06-02 |
Satsuma Pharmaceuticals Inc. | STSA | TAKANASHI KEN Director |
30,000 | $0 | 1,591,719 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 5:36 pm |
N/A 2032-06-02 |
Satsuma Pharmaceuticals Inc. | STSA | Harsch Mutya Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 5:35 pm |
N/A 2032-06-02 |
Satsuma Pharmaceuticals Inc. | STSA | Soloway Thomas P Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 5:34 pm |
N/A 2032-06-02 |
Satsuma Pharmaceuticals Inc. | STSA | KING THOMAS BRAXTON Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 5:34 pm |
N/A 2032-06-02 |
Satsuma Pharmaceuticals Inc. | STSA | Riebe Michael T Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 5:31 pm |
N/A 2032-06-02 |
Satsuma Pharmaceuticals Inc. | STSA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
30,000 | $0 | 30,000 (Indirect) |
View |
Ownership |
2021-10-19 5:09 pm |
N/A N/A |
Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner |
0 | $0 | 3,208,761 (Indirect) |
View |